NAFDAC Begins Malaria Vaccine Clinical Trial in Nigeria

The Director General of NAFDAC, Prof. Mojisola Adeyeye, dropped the hint at the weekend, at the Pharmacovigilance Inspection interactive session with Pharma Stakeholders in Lagos.

She said the agency was about to begin a Malaria Vaccine Clinical trial as part of its resolve to exterminate malaria scourge in Nigeria.